Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zephyr Etude Post-Inscription (French Registry)

NCT04517916 is registered in ClinicalTrials.gov with Pulmonx Corporation as lead sponsor.

NCT NCT04517916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04517916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zephyr Etude Post-Inscription (French Registry)
Lead sponsor
Pulmonx Corporation
Phase
Observational
Overall status
Completed
Start date
January 4, 2021
Completion date
January 28, 2026
Enrollment
155 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema or copd